Five-year complete remission of super-giant hepatocellular carcinoma with hepatectomy followed by sorafenib plus camrelizumab: A case report
The combination of hepatectomy with sorafenib and camrelizumab can achieve durable CR in patients with super-giant HCC and portal vein invasion. Further research is necessary to address these challenges and improve patient outcomes.
Authors
- Huiguo Ding (ORCID: https://orcid.org/0000-0002-8716-4926)
- Libo Sun (ORCID: https://orcid.org/0000-0002-5006-8455)
- Chunyan Gou
- Wenjie Jin (ORCID: https://orcid.org/0009-0007-8995-9312)
- Xiaojun Wang (ORCID: https://orcid.org/0000-0003-1506-0762)
- Xiaoqin Zheng (ORCID: https://orcid.org/0000-0001-8844-8536)
- Wenyan Song (ORCID: https://orcid.org/0000-0001-8074-500X)
- Hui Liu (ORCID: https://orcid.org/0000-0001-9452-6334)
- Jushan Wu
- Hui Xu
Institutions
- Capital Medical University (CN)
- Beijing YouAn Hospital (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Surgery
- Published
- 2024-12-27
- DOI
- https://doi.org/10.4240/wjgs.v17.i1.99752
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00